As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4063 Comments
1844 Likes
1
Averiee
Consistent User
2 hours ago
Recent market gains appear to be driven by sector rotation.
๐ 18
Reply
2
Margueritte
Experienced Member
5 hours ago
Market volatility remains elevated, signaling caution for traders.
๐ 22
Reply
3
Dajean
Engaged Reader
1 day ago
Free US stock growth rate analysis and revenue trajectory projections for identifying fast-growing companies. Our growth research helps you find companies with accelerating momentum that could deliver exceptional returns.
๐ 193
Reply
4
Krysha
Community Member
1 day ago
Incredible, Iโm officially jealous. ๐
๐ 145
Reply
5
Kalyia
New Visitor
2 days ago
Useful for assessing potential opportunities and risks.
๐ 102
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.